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Antimicrobial resistance (AMR) has been identified 
by the global health community, in particular 
within the European Union and in the United 
States, as one of the greatest threats to life as we 
know it. The impact of antimicrobial resistance 
could be dramatic (Jasovsky, Littmann, Zorzet, & 
Cars, 2016). Action taken to counter-act AMR could 
be equally dramatic. In both cases AMR is set to re-
configure our relationship with medicines and 
therefore to have a profound impact on the 
possibilities for care and health around the globe.  
 
Despite the social and political nature of 
pharmaceuticals and their use, there has been a 
surprising lack of input from the social sciences in 
informing courses of action (Smith, 2015). Without 
such active engagement, effective means of 
addressing AMR may be missed, and risks of 
adverse consequences of policies and programmes 
may be increased if they lack sensitivity and 
responsiveness to global and local entanglements 
with antimicrobials.  
 
There is great potential to learn from the 
considerable theoretical work across the social 
sciences, so as to provide a broader and richer 
conceptual map through which effective strategies 
to tackle AMR could be created. In this report we 
review social theories that may be relevant to AMR, 
with a focus on an anthropological perspective, 
and set out how these theories may usefully be 
applied to understanding AMR and identifying 
responses to AMR. In so-doing, we hope to engage 
the reader in thinking about the social dimensions 
of this issue within and beyond the framing of 
‘behaviour’. 
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This report addresses three domains for the study 
of AMR: practice, policy and science. Each deserves 
attention as objects for analysis, although the three 
domains are inter-related, with concepts, framings 
and expectations travelling between all three. 
 
 
 
Figure 1: AMR practice, policy and science domains and their inter-relations 
 
 
 
 
 
 
 
 
 
 
 
 
The domain most often associated with social 
research in relation to a topic like AMR is practice: 
how, when and why medicines are used in different 
contexts. This is a core concern for social theory, 
looking at the ways in which antimicrobials are 
embedded in our societies. However, in this report 
we also reflect a wider range of social theory that 
can be been applied to the domains of policy and 
science: how, when and why AMR policy objects 
and scientific facts are produced. In all three 
domains, we hope to enable readers to move 
beyond the remit of ‘behaviour’ of patients, 
prescribers and farmers, to explore wider social, 
material and other lives that make up the field of 
AMR, and to open these up to social analysis.  
 
To do this, we ask 'what is at stake' as AMR is 
enacted (debated, discussed, identified and acted 
upon) and what forms therefore emerge as AMR in 
different settings.  
 
Recent anthropological approaches that seek to 
take into account the material as well as the 
cultural and which shift the concern of 
ethnographic research away from questions that 
are mostly about knowledge (what and how do we 
know about the world?) - to ones that are more 
concerned with the nature of the world - are 
particularly pertinent for research on AMR. They 
often place forms of categorization and objects at 
the heart of the analysis and demonstrate that 
what appears to be static, singular and fixed is 
often better understood as multiple and dynamic 
Practice
Policy
Anti-
microbials
Science
Metrics, forecasting, modelling 
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in nature, shaped by both material and 
social/cultural forces in which it is embedded. For 
AMR, this means that rather than starting with 
questions that ask about human behaviour the 
interest revolves around interrogating concepts 
(for example what constitutes the 'rational', 
'irrational' or 'prudent' use of antibiotics in 
different settings, how and why this changes); 
scientific practice and debates; guidelines, legal 
frameworks and regulations; infrastructures, 
training and capacity building strategies that 
emerge when AMR is in play (as a discourse, social 
practice and natural fact). Through such analyses it 
is possible to explore AMR as an assemblage that is 
as political, social and cultural as it is biological and 
to examine the shape that it takes in different 
settings.  
 
The perspectives of the authors of this report draw 
on Jensen’s interpretation of Deleuze (Jensen, 
2012) and on Marcus (Marcus, 1995): we are 
interested in constructing a theoretical framework 
to engage anthropology as a following science 
concerned with the ways in which AMR gets made 
and remade, how different elements of the social 
and material world labelled AMR become more or 
less important as it enters different settings and 
the ways in which AMR is held together as an 
object and rendered coherent.  
 
There are thus three Parts to the report: Part 1 
Practice; Part 2 Policy and Part 3 Science. In each, 
we begin with a review of theory of potential 
relevance to investigating AMR, and then move to 
illustrate application of some of these theoretical 
approaches in relation to AMR. Our intention is 
both to bring to life these approaches for the 
benefit of readers new to the integration of social 
science and AMR practice. In addition, we provide 
new insights into thinking about and addressing 
AMR, which summarise findings that are 
developed in more detail and presented 
elsewhere.
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Anthropologists have been studying medicines and 
the ways in which humans relate to them for the 
past century. Such work is informative for 
interpreting the role antimicrobials have in health 
and healthcare, looking at the range of places and 
spaces in which these medicines enable particular 
forms of life, social worlds and infrastructural 
arrangements. This empirical and theoretical work 
can provide insights into how reliance on 
antimicrobials might be reduced and the potential 
consequences of doing so. Here I summarise 
anthropological work that has focused first on the 
use of medicines, by consumers and prescribers, 
and second on the meanings of medicines, for 
patients and providers. This section will draw 
primarily from anthropological theory but will also 
draw on sociological theory to a lesser extent. 
Readers are directed to a summary of sociological 
perspectives on AMR by Wood (Wood, 2016). 
 
 
Review of relevant theory 
Use of medicines 
Throughout the history of the sub-discipline, 
medical anthropology research has drawn 
attention to cultural, social, political and economic 
structures that shape the distribution of disease as 
well as access to biomedical treatment. In this line 
of research, anthropologists have recognised the 
importance of antimicrobials in alleviating 
suffering, and have worked (primarily in Low and 
Middle Income Countries (LMICs)) to understand 
how access to and use of essential medicines could 
be improved (Manderson, 1998).  
 
Use of medicines by consumers 
The Essential Medicines movement, championed 
by the World Health Organisation after its 
publication of the first essential medicines list in 
1977, enlisted anthropologists into multi-
disciplinary teams to identify ways to increase 
access to and rational use of medicines considered 
vital tools to improve and maintain health (. World 
Health Organisation, 1985). With rational use 
defined by biomedical science, anthropologists 
provided evidence of consumers’ own rationalities 
for use of medicines. These studies have shown for 
example how medicines were used to treat 
symptoms rather than a particular disease 
(Feierman, 1981); to self-medicate common or 
‘ordinary’ illnesses such as fever (Kamat, 2006); 
and to take medicines until symptoms have ceased 
(Nichter, 2008). Numerous studies also sought to 
characterise how people would identify medicines 
as particularly efficacious, or compatible. For 
example, colour, taste and appearance as well as 
form such as injection, intravenous fluid or oral 
tablets, could all indicate the efficacy, strength and 
tolerability of drugs (S.R. Whyte, Van der Geest, & 
Hardon, 2002). These accounts have illustrated 
diversity in perceptions of particular medicine 
types or characteristics, both between and within 
settings. In many cases, medicine efficacy has been 
found to be locally or individually contingent; what 
works for one person might not for the next, and 
different dosages, timings and ways of taking 
medicines would need to be experimented with on 
a case by case basis (Nichter, 2008). These findings 
often draw contrasts with international 
standardised guidelines, demonstrating a gap 
between local and global perspectives of what was 
‘appropriate’, ‘rational’ and ‘proper’. 
 
 
 
Beyond the focus on characteristics of medicines 
themselves, anthropologists have also highlighted 
their use in reference to local conceptualisations of 
causality of illness as well as locally correct modes 
of healing. This could be depicted through 
explanatory models, which describe cultural ideas 
about illness and were proposed in the 1970s as 
ways to understand and negotiate different 
perspectives of ill-health and misfortune (e.g. 
Kleinman, Eisenberg, & Good, 1978). This would 
enable anthropologists to work with biomedical 
practitioners to bring together local aetiologies and 
priorities with biomedical knowledges and 
resources (e.g. Helman, 1984). Such models can 
still be informative. For example, Mark Nichter’s 
ethnographic work in the Philippines provides a 
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rich description of preventive and protective 
antibiotic use by patrons of sex workers, who 
variously took antibiotics before sex, after sex, 
occasionally or routinely depending upon their 
own situations and familiarity with the particular 
sex worker (Nichter, 2001). His analysis 
demonstrates how the use of these medicines can 
be interpreted in terms of vulnerability and 
‘streetwise attempts to exercise agency’ in 
reducing harm, p117). However, in casting these 
behaviours as ‘misguided’, there appears an 
assumption that there is a ‘correct’ way to use 
these medicines. In the light of shifting biomedical 
knowledge over time, and between scientific 
disciplines, this assumption has been called into 
question, especially when there is an implicit 
dichotomy of biomedical knowledge as ‘true’ and 
local knowledge as ‘belief’. As anthropologists 
increasingly drawn attention to the complex set of 
beliefs embedded in biomedical science and 
practice itself, the proposal to ‘convert’ local 
populations to the ‘correct’ way of thinking 
became seen as problematic (Bibeau, 1997). 
Anthropologists have also questioned whether the 
focus on such beliefs, which may not relate to 
behaviours, is the reason why knowledge or 
education based programmes have often been 
unsuccessful in changing health practices (Yoder, 
1997).  
 
The early 1990s saw a shift in focus away from 
beliefs of individuals or local ‘cultures’ (the 
characterisation of which had come under scrutiny, 
see Clifford & Marcus, 1986) and anthropologists 
began more commonly to document wider social, 
political and economic structures affecting, 
amongst other things, access to medicines for 
infectious diseases. The inequalities shaping 
occurrence of disease as well as access to 
treatment were increasingly documented (Singer, 
1990). The concept of ‘structural violence’ gained 
traction in anthropological analyses, referring to 
the injury caused by inequitable regulations and 
categories imposed upon people by structural 
systems or governing institutions (Galtung, 1969). 
Paul Farmer popularised the concept in relation to 
health (e.g. Farmer, 2005), and this has been 
influential in shifting responsibilities, for example 
for HIV treatment from citizens to states, with 
antiretroviral treatment becoming conceived as a 
human right. In many ways this underscored the 
centrality of medicines in development efforts and 
programmes such as the U.S. President’s 
Emergency Plan for AIDS Relief (PEPFAR) and the 
Global Fund to Fight AIDS, Tuberculosis and 
Malaria, made the delivery of antiretrovirals, 
antibiotics and antimalarials the cornerstone of 
philanthropic aid. Despite this push to increase 
availability of these essential medicines, 
anthropologists have drawn attention to realities 
on the ground of continued disparities and 
interruptions in access to medicines through these 
programmes as well as through collateral damage 
to health systems of narrow interventions (Pfeiffer, 
Nichter, & Critical Anthropology of Global Health 
Special Interest, 2008). Rather than addressing 
structural violence, it has been argued that such 
programmes can reinforce these problems 
(Cameron, 2011).  With regards to drug resistance, 
concerns around poor and marginalised groups as 
most vulnerable to infectious diseases carry over to 
those most vulnerable to resistant infectious. 
Farmer has proposed that the concept of structural 
violence is useful to understand both access and 
adherence to therapy (Farmer, Nizeye, Stulac, & 
Keshavjee, 2006), which affects the development 
of resistance and ability to manage resistant cases. 
Furthermore, if access to medicines is to be 
restricted through efforts to halt resistance, then 
in many cases where access is already poor, this 
may exacerbate these problems. The impact on 
this in terms of cases and costs has been 
approximated (Mendelson et al., 2015) but the 
social costs remain unexplored. 
 
Use of medicines by prescribers 
As early as the 1950s there was substantial 
discussion over when antimicrobial use should be 
classified as inappropriate, misuse or abuse. 
Consensus has not been easily reached, with 
physicians at the time making recommendations at 
the extremes: to restrict antibiotics to ‘emergency 
therapeutic crutches to be used only in seriously 
threatening conditions’ versus to use penicillin or a 
combination of antibiotics to treat flu or severe 
viral infections (Podolsky, 2015 p115 citing Arthur 
Lawrie Tatum and Henry Sweany respectively).  
 
Concerns of over-use of antibiotics appear in some 
historic and anthropological analyses to be 
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tolerated because of the apparent lack of choice 
for physicians. Even when a majority of antibiotic 
uses were classified as ‘irrational’, this critique 
could be countered with arguments of insufficient 
diagnostic testing (Podolsky, 2015).  Unlike 
diagnostic tests, which can raise more uncertainty 
when negative, empirical treatment allows for both 
the possibility of the treatment to be effective and 
for time to improve the patient. It also prevents the 
situation of a worse outcome due to not treating. 
Anxiety over the potential consequences of missing 
a case requiring an antimicrobial have loomed 
large since these substances have been available 
for widespread use. Historian Robert Bud 
summarises accounts of doctors thus, ‘Whatever 
the probable diagnosis, were something to go 
unexpectedly awry then other people, and perhaps 
even they themselves, would ask why antibiotics 
had not been tried’ (R. Bud, 2007b p153). The 
uncertainty over when antibiotics are required has 
persisted. This ambigious response to increasing 
concerns over risks posed by inaction can be 
interpreted in the light of increasingly risk-aware 
‘risk societies’ of the modern era (Beck, 1992). 
Anthropologists and sociologists have continued to 
document the triad of diagnostic uncertainty, 
demanding patients and the fear of untreated 
serious disease as central to prescribing practice 
through the decades since the 1950s (e.g. Cabral, 
Lucas, Ingram, Hay, & Horwood, 2015).(Cabral et 
al., 2015). Nonetheless, the notion of ‘rational 
therapeutics’ has persisted, with ‘a sceptical, as 
well as a moral, tone, to be juxtaposed to the 
influences of commerce, ignorance, or intellectual 
lassitude’ (Podolsky, 2015 p113). This area is ripe 
for further anthropological analysis.  
 
 
 
Clare Chandler. Routine antimicrobial treatment at a Ugandan health centre 
Meanings of medicines 
Beyond the use of medicines for their biological 
functions, anthropologists have examined how 
these objects take on other meanings and roles in 
different arenas, considering pharmaceuticals as 
entities that operate beyond their curative 
properties. This body of work is instructive for 
interpreting how antimicrobials are used, 
prescribed, marketed and integrated into agendas 
from patients to prescribers to pharmaceutical 
companies to governments and global bodies. This 
can provide insights into the challenges faced by 
11
attempts to reduce or target medicine use, given 
their values beyond biological function.  
 
The charm of medicines 
Even amongst biomedical scientists, these 
substances have an enigmatic air, for example in 
the way they are referenced as ‘magic’ bullets. The 
use of this term provides an invitation for 
anthropological analysis, given the way magic has 
been a central analytic in classical anthropology 
(see for example Evans-Prichard, 1937; 
Malinowski, 1948). In reference to antimicrobials, 
‘magic’ evokes both the power and potential super-
power of such substances and their relations to our 
material and social realities. Moving this further, 
anthropologists Sjaak van der Geest and Susan 
Reynolds Whyte have described medicines as 
having ‘charm’, providing a concrete solution to ill-
health, and one that can be separated from a 
therapeutic encounter. This distinguishes 
medicines from other forms of healing such as 
surgery, which cannot be separated from a 
surgeon. Medicines are democratic and exoteric, 
they are ‘widely believed to contain the power of 
healing in themselves. Anyone who gains access to 
them can apply their power’ (Van der Geest & 
Whyte, 1989 p346). The same authors extended 
this perspective to incorporate a wide range of 
places and spaces where medicines flow, are 
exchanged as commodities, are prescribed and 
consumed. After Appadurai’s The Social Life of 
Things, they invoke an analytical framework of the 
‘Social Lives of Medicines’, proposing that as things, 
medicines have biographies (S.R. Whyte et al., 
2002). The authors trace the careers of medicines, 
often antimicrobial, and provide useful context for 
the ways in which these substances travel beyond 
the enclave of professional control and are made 
common. In drawing together a range of 
anthropological works, through which they 
illustrate how people in different settings, roles 
and industries, employ these substances for 
various endeavours, this volume is compelling in 
arguing that medicines should be understood 
beyond their capacity to cure (or poison).  
 
The charm of pharmaceuticals, as concrete entities 
with wider symbolic, economic and political value, 
is a useful lens through which to consider how 
antimicrobial resistance may arise as well as how it 
may be tackled, especially in relation to the drivers 
of antimicrobial use. We can look at the value of 
antimicrobials for different actors in order to gain 
insights into the status quo, important to consider 
if intervention is to be undertaken, both to design 
effective interventions and to anticipate potential 
consequences beyond impact on AMR. 
 
 
Clare Chandler. Antimalarial medicines 
 
Meanings and contexts of medicines for patients 
The anthropological literature on the use of 
antimicrobials by patients is vast. Some concepts 
that may be useful in considering the appeal of 
antimicrobials, even when their use is termed 
‘irrational’ or ‘inappropriate’ for a particular case, 
are reviewed here including their symbolic value, 
their role in rituals of care, what has been termed 
the ‘placebo’ effect, and fourth the ability to tailor 
purchases according to affordability. 
 
First, the concreteness of antimicrobials as a 
solution, helps to define the problem in a more 
concrete manner – it enhances the perception of 
illness as something tangible, which may be 
manipulated (Van der Geest & Whyte, 1989). This 
adds to the observation that a doctor’s prescription 
serves a legitimising function, allowing an 
individual to take on a sick role (Parsons, 1951). A 
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crucial distinction with this earlier theory, 
however, is that medicines can be detached from 
the professional encounter. In many settings they 
can be purchased. However, more than simple 
commodities, medicines (especially of the 
antimicrobial variety) carry built-in associations 
with knowledgeable doctors and with 
technological sophistication. Following ideas from 
classical anthropology about the symbolic value of 
apparently every-day goods, antimicrobials carry 
with them the characteristics of biomedicine as a 
broader system.  
 
Second, leading from the semi-autonomous nature 
of these medicines, antimicrobials can be adapted 
and adopted within other medical systems, sold 
outside of medical settings, and used as self-
medication. For example, capsules can be opened 
and sprinkled on wounds; tablets can be mixed 
with others into ‘cocktails’, and can form part of a 
process of care involving other traditions and 
rituals (Haak & Hardon, 1988; S. R. Whyte, 1992). 
Self-medication has been a fascination of the 
public health research community, assumed to be 
undesirable as consumers are believed not to have 
correct knowledge (Haak & Radyowijati, 2010). 
Anthropologists have applied frameworks from 
comparative medical systems work (such as the 
three sectors: popular, professional and folk) to 
understand antimicrobial use in lay networks, 
medicine sellers, pharmacies and so on (see Whyte 
et al. (2002) and Haak & Radyowijati (2010)). 
Anthropological documentation of the every-day 
practices of informal providers and their clients 
(such as Sringernyuang, 2000; van der Geest, 1982, 
1987), have opened up for investigation and 
intervention a wide range of locations in which 
antimicrobials were being traded and consumed 
(S.R. Whyte et al., 2002). 
 
Third, the experienced effects of a drug may not 
align with biomedical expectations of its active 
ingredients; an ‘inert’ pill may have a positive 
impact on the patient. This has been termed a 
placebo (literally, ‘I shall please’) effect. 
Anthropologists have studied this as part of the 
human healing process, in which the pill has 
become a symbol carrying meaning within 
particular events, relationships and histories (see 
Moerman (2000) and Whyte et al. (2002)). The 
confidence and expectation built into a pill, which 
reflects a wider set of relations and experiences, is 
enacted in a biomedical encounter with some self-
awareness on behalf of both prescribers and 
patients. In Cameroon, clinicians openly recognised 
that they were providing ‘psychological treatment’ 
to patients in the form of pills, as well as diagnostics 
(Chandler et al., 2012). The authority and power of 
such biomedical commodities appears an 
important part of such processes of healing. 
 
Fourth, medicines are appealing for every day 
economic reasons. These include the possibility to 
start and stop treatment at will, including to save 
or share drugs; to purchase the amount that can be 
afforded (van der Geest, 1987) and also the 
anticipation that by taking these medicines one can 
return to work rather than requiring time to 
recover (Chandler et al., 2011; Vuckovic, 1999). 
Each of these issues is important to consider in 
scenarios where medicines require out-of-pocket-
payments and where day-wage labour is common.  
 
Because of these different charms of medicines, 
they may be integrated into multiple forms of 
healing. There is a vast anthropological literature 
on medical pluralism – where multiple systems of 
healing are seen to exist as alternative or inter-
related systems where patients access care. This 
work is informative in contextualising access to 
antimicrobials, which may be sourced in small 
shops, by a range of healers, in market places, 
pharmacies, private and public biomedical 
practitioners. In heterogeneous health sectors, 
patients may easily switch between providers 
depending upon the success with one or the other 
during a particular episode, called ‘medical 
syncretism’.  
 
In sum, patients can be seen through 
anthropological studies as experts on how to elicit 
and accomplish the healing that they regard will be 
most likely to ‘work’ for them. ‘Just as men and 
women infrequently behave as the rational, 
economic actors envisioned by health planners and 
policymakers, what they know to be true about 
health, illness, disease and medicine is often not 
what biomedical clinicians want them to know’ 
(Foley, 2010 p6). 
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Meaning and contexts of medicines for providers 
Research into the rational use of medicines has 
identified that prescriber ‘irrational’ use of 
antimicrobials is at least in part due to matters 
beyond the perceived medical suitability of a 
particular drug for a particular patient.  
 
The context of care shapes the meaning of 
medicines for both providers and patients. 
Kleinman’s professional, folk and popular sectors 
model in which different social relations as well as 
clinical realities were key characteristics (Kleinman, 
1980) has been developed further particularly with 
empirical studies of informal medicine sellers. 
Whyte and colleagues draw attention to drug 
shops as a common feature in many health systems 
but which fits uneasily into this model. They 
highlight that a key characteristic of such sources 
of medicines is that ‘going to a drugstore to seek 
health care allows one to retain more control while 
still taking advantage of the knowledgeability of the 
retailer, whether certified pharmacist or 
experienced drugstore attendant.’ (2002 p100). 
Cross & MacGregor (2010) additionally examine 
the way informal providers are portrayed in global 
health literature. They highlight the ways in which 
descriptions such as ‘irrational’ are ‘deeply 
entwined with prejudices and pre-conceptions 
based on hierarchies of caste, class, gender or 
ethnicity’ (p1595). They expand, ‘the portrait of 
irrational village practitioners and their fatalistic 
rural patients also marks a social hierarchy 
between agents of development and the people 
they target, so that lay knowledge or practice 
comes to be defined by and against the rational, 
educated, elite cosmopolitan’. These practitioners 
then, can be seen as ‘those against whom the 
educated and rational self is defined’ (Pinto, 2004). 
This relativist perspective of the placings of 
different actors by those operating in global health 
is crucial for interpreting medicines use studies – 
their findings and their framings. 
 
Anthropological research, then, has attempted to 
situate medicines as they are prescribed, sold, 
traded within local networks of relations 
embedded in particular histories, legacies and 
political economies. This body of research and its 
legacy allows us to see medicines as a central  
 
Justice Police Officer inspecting a Pailin pharmacy’s display 
cabinet. WHO/Moeun Chhean Nariddh (2011) 
 
symbol of biomedical and other forms of care 
provision. The concrete nature of medicines, or in 
their stead a medical prescription, is seen as crucial 
to their charm for providers as much as for 
patients. Thus, anthropological studies have 
revealed the ritual elements of consultations that 
providers employ with their clients or patients, 
with medicines as a closing ritual.  
 
The need to provide a ‘strong’ medicine, such as an 
antimicrobial, rather than a ‘simple’ medicine such 
as paracetamol has been contextualised in 
anthropological studies by the importance for 
prescribers of maintaining status as a gatekeeper 
for biomedicine. For medical professionals, their 
authority can be maintained by their ability to write 
prescriptions and provide access to medicines 
patients are ‘not supposed’ to obtain from others 
(S.R. Whyte et al., 2002). It may also relate to the 
‘placebo’ effect described above, whereby faith of 
both the practitioner and the client in the medicine 
can result in an improvement in outcome even if 
the medicine does not contain the properties 
biologically required (Moerman, 2000). Thus, even 
if guidelines suggest a particular management of 
for example diarrhoea with oral rehydration 
solution (ORS), there may be numerous reasons 
why antimicrobial treatment is instead or 
additionally provided, including the devalued 
status of ORS by comparison (Howteerakul, 
Higginbotham, Freeman, & Dibley, 2003). 
 
The reasons that medicines or prescribing has 
become the desired outcome are also of interest to 
anthropologists. Historically, antibiotics enabled a 
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new basis for authority of physicians, and became 
woven into the consultation process. With time 
pressures and high patient numbers, antibiotics 
often replaced the time that a patient may have 
once received from a doctor. Pressured doctors 
could speed up throughput by writing antibiotic 
prescriptions (R. Bud, 2007b). Another reason 
anthropologists have described for consultations 
culminating in medicines or a prescription is as a 
way of dealing with uncertainty and emotional 
concern; ‘prescription fits the impulse of modern 
man to control his own destiny, to take the 
problem in hand and conquer it with technology’ 
(Pellegrino, 1976 p626). Here, we can see how the 
matter of medicines use or prescription, moves 
well beyond the biological needs for a particular 
drug in a particular case. It has become an 
expected part of the clinical encounter, embedded 
in the rituals of providing care, as well as a 
technological solution during health encounters 
where there is limited time to provide care for each 
individual patient.  
 
 
 
 
 
 
Application of theory 
This section illustrates how the social (primarily 
anthropological) theory introduced in the 
preceding pages can be drawn upon to see 
something different in our landscapes of 
antimicrobial use. Specifically, two areas will be 
developed, to attend to the complex realities of 
attempting to target antimicrobial medicines and 
to consider the multiple functions antimicrobials 
have in society as they form a part of our 
infrastructure. These perspectives allow us then to 
consider what may be at stake when shifts come 
about in our ability to use these medicines. 
 
The complex realities of targeting antimicrobial 
medicines 
Targeting antimicrobial medicines is central to the 
rhetoric of preserving their efficacy (see for 
example, Wellcome Trust, 2016). Targeting has 
been attempted through regulation, such as 
prescription vs over-the-counter access to 
medicines, implementation of clinical guidelines on 
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prescribing, use of diagnostic testing in 
combination with clinical guidelines and other 
incentive schemes to drive reduced prescribing. 
Drawing on the perspectives outlined in the theory 
review above, it is possible for us to apply different 
theoretical lenses to the lived experiences of 
targeting in order to interpret why often these 
measures have limited impact on the outcomes 
they strive to achieve. We can come to see how the 
idea of targeting, which carries an idea of 
improving access, can in the event be experienced 
as the inverse, as rationing or denial of medicines. 
This has been well documented in the field of 
antimalarial targeting. Revised clinical guidelines 
and new point of care rapid diagnostic tests (RDTs) 
have been implemented widely in order to reduce 
overuse of antimalarial medicines, but in many 
cases antimalarials have continued to be 
prescribed even when RDT results are negative for 
malaria (for an overview, see Rao, Schellenberg, & 
Ghani, 2013). Anthropological work alongside the 
implementation of these tests has highlighted how 
both prescribers and patients see these tests as 
qualifying and disqualifying patients from getting 
medicines (Beisel, Umlauf, Hutchinson, & 
Chandler, 2016). In the knowledge of these 
disqualifying technologies, patients have been 
documented to avoid health centres that use these 
tests where their established modes of care are 
disrupted (Umlauf, 2017).  
 
These scenarios where targeting medicines is 
experienced as denial, raise the question of what is 
provided in healthcare in the absence of 
medicines. Furthermore, patients, carers and 
health workers are alert to the limitations of care 
beyond medicines – they may replace one 
antimicrobial with another (antimalarials 
substituted for antibacterials for example, see 
Hopkins et al., Forthcoming), or there may simply 
be no care. To manage the latter, health workers 
have been observed to shift their role and 
allegiance, becoming a limb of a prescriptive 
state/donor entity rather than an ally of the patient 
for whom the health worker can do little 
(Hutchinson et al., 2015). The patient may then be 
cast as not ‘deserving’ of care altogether when not 
qualifying for particular medicines, as was reported 
by Ugandan health workers (Chandler et al. 
forthcoming). This aligns with critiques of Western 
medicine as having moved from a pre-modern era 
of holistic healing to ‘modern’ in which other 
aspects of care are stripped away in an attempt to 
cure (Gray, 1999). Elements stripped away are then 
sought elsewhere for example in other healing 
systems. Reflecting on this scenario in which care is 
based on specialties rather than on the person, 
there have been high profile calls for ‘integrated 
medicine’ that again resituates the patient rather 
than technologies at the heart of services (His 
Royal Highness The Prince of Wales, 2012).  
 
Why do we resist this suggested ‘integrated 
medicine’? Initial responses revolve around cost, 
and cost-effectiveness. This contextualising of care 
as operating within limits of affordability, 
perspectives on rationality and promise of 
technology highlight that targeting of medicines 
occurs within health care systems that are 
embedded in particular economic and political 
frameworks, that have an interest both in providing 
care to ensure wellbeing and productivity of 
populations, but also to securing the economic 
position of a given country which usually relies on 
a capitalist business model, in which Big Pharma is 
to be courted (Katz, 2005).  
 
When considering how targeting initiatives travel 
to other settings, we are also then aware of how 
the nature of these initiatives relates not only to 
improving health in the most effective way but to 
also achieve other goals, priorities and mandates of 
donors. 
 
Antimicrobials as infrastructure 
The fear that a threat to antimicrobials signifies the 
end of modern medicine demonstrates how 
important these medicines are understood to be: 
across a breadth of medical practice from 
infectious diseases to surgery, such as hip 
replacements or caesarean sections. This also 
provides a useful opportunity for us, to see what is 
taken for granted in the current infrastructure into 
which these medicines are woven. Drawing on Star 
and Bowker, who work to make infrastructure 
apparent, in a ‘struggle against the tendency of 
infrastructure to disappear’, it is possible to 
identify the characteristics of an effective 
infrastructure through technique of inversion 
(Bowker & Star, 2000). By looking closely at 
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technologies and arrangements that, ‘by design 
and by habit, tend to fade into the woodwork 
(p34), we can begin to see what things in our 
material and semiotic networks support this 
position of antimicrobials and make them so 
difficult to remove. 
 
Three examples are: how antimicrobials are 
intertwined with our infrastructure through ideas 
of productivity, such as expectations around time 
to recovery. An inversion would be convalescence, 
which provides a counterfactual through which to 
explore existing (often invisible) infrastructure. A 
second example could be how antimicrobials are 
interwoven into our food infrastructure through 
standardisation. An inversion could be the artisanal 
movement which throws up the material and 
immaterial hooks upon which our food 
infrastructure hangs. A third example could be how 
antimicrobials are interwoven into our sanitation 
practices across scales from disgust responses to 
vast spaces frequently in receipt of antimicrobial 
spraying. An inversion could be faecal transplants 
or the increasingly popular dirt hypothesis. In all of 
these cases, the inversion allows us to see our oft 
unseen infrastructure. 
 
 
These cases then may prompt us to ask whether 
this infrastructure can change? We can ask 
individuals to change – to stop taking 
antimicrobials, to stop using them in food chains 
and to increase exposure to microbes – but we 
know this is difficult to do. By paying attention to 
the infrastructure that these behaviours are 
embedded in, we can begin to see what it would 
take to achieve these behaviours, or at least to 
state more clearly what is at stake. 
 
Possibilities for change have provoked a question 
of ‘what would a postmodern medicine’ look like? 
Some observers suggest that this era is already 
here (Gray, 1999). These processes may well 
dovetail with demands for reducing reliance on 
antimicrobials. Infrastructure, however, may 
require deliberate intervention to change, 
specifically attending to values of productivity and 
time, of standardisation, and of sanitisation. When 
we see deeper societal, economic and 
international relational pillars that support this 
infrastructure, we can begin to see the scale at 
which shifts would be required to make a 
substantial difference to antimicrobial use. The 
view then renders the current emphasis on 
cognitive awareness and behaviour change as 
somewhat limited in potential to impact upon 
antimicrobials. It could even be proposed that by 
focusing on this tip rather than the iceburg, the 
status quo of pharmaceuticalisation is secured and 
reinforced, as is seen with the desire and 
investment in further medicine alternatives (see 
Part 2 AMR Policy).   
 
To conclude, this part of the report has described 
theories used to understand antimicrobial usage in 
practice, and has provided illustrations of how 
these theories can be applied. In so doing, it has 
raised observations that allow for different 
perspectives to be taken to the ways we consider 
the ‘problem’ and potential solutions. In summary, 
a focus on human behaviour in understanding 
antimicrobial use is just the tip of the iceburg. 
"Every Minute Lost on this Job may Mean.. (Unknown, 1941- 1945)." 
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Review of relevant theory 
 
The anthropology of policy 
Since the beginning of modern anthropology, 
anthropologists have provided knowledge for 
policy-makers including analyses of the impact of 
particular policies upon different groups of people 
(Cochrane, 1980; Hinshaw, 1980). Such tasks 
remain a central part of the work done by many 
applied anthropologists whose instrumental 
interactions with policy means that they see their 
task as making development policy more effective 
and equitable. Their work has had a significant 
influence enabling concepts of participation, 
empowerment and social capital to become part of 
the lexicon of development. Yet, fundamental 
shifts in the discipline in the 1980s, meant that a 
new approach to policy as a human endeavour that 
was both historically and culturally embedded 
emerged (Shore & Wright, 1997). This 
‘anthropology of policy’ grew out of 
anthropological analyses of organisations (Wright, 
1994, 2004), influenced by the interest in “studying 
up” (Nader, 1972).  
 
Anthropological accounts of policy offer useful 
insights into how to conceptualise policy as a 
process and as a means of managing social change. 
As they follow the formation of formal and informal 
social relations and the real life situations of those 
seeking to formulate policy, anthropological 
accounts tend to reject what has been described as 
an instrumentalist view of policy as a technical, top 
down means of managing society (Shore & Wright, 
2011). Instead, heavily influenced by Foucault, they 
suggest that accounts of bureaucratic influence in 
society, policy discourse and narrative such as 
those around AMR must be examined as a means 
of extending power through late modern forms of 
governance. These policy discourses locate 
problems in particular spheres by defining the ways 
in which they are perceived of, to be acted upon 
and the ways in which particular forms of 
governmentality come about (Hyatt, 2011). New 
policies often shut down other ways of thinking 
through the issue at hand as they formulate their 
response to the problem thus limiting how we can 
act on a problem (Shore & Wright, 1997). In 
relation to AMR, the literature suggests that we 
should critically evaluate the focus on individuals 
(doctors, patients, drug sellers and their 
customers) as the locus of problematic behaviour 
that drive of AMR. Instead or alongside this, we 
should also critically assess why the problem is 
identified at this level and examine how the social, 
medical and political structures within which these 
individuals live and work, how it is that these 
structures are excluded from relevant discourses 
and the consequences of this exclusion.  
 
Analyses of policy by anthropologists have also 
been concerned with the metaphors and symbols 
that are contained within policy narratives and the 
way in which these are implicated in the 
construction of new forms of moral personhood 
(the creation of new subjects and new kinds of 
subjectivity) in policy discourse and in its 
translation into practice (Nielsen, 2011). Such an 
approach asks us to consider how policy works as 
an actant, that is how it comes to be productive in 
ways not necessarily considered by those who have 
drawn it up.  
 
 
United Nations Global Health Assembly September 2016, 
Shutterstock 
 
Accounts of the anthropology of global health that 
look closely at policy and its implementation within 
bureaucratic settings (Storeng, 2014; Storeng & 
Mishra, 2014; Taylor & Harper, 2014) remain 
relatively rare. In contrast, a critical ethnographic 
gaze has been brought to bear on powerful actors 
working in bureaucracies and development 
organisations who formulate policy and those who 
reinterpret it into other settings (Mosse, 2004, 
2011) (Müller, 2013). 
 
These ethnographic studies of policy and 
governance go beyond documentary analysis and 
complement constructivist accounts of global 
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policy-making and governance from international 
law and in policy studies. In both subjects, political 
and legal negotiations are understood as messy 
and contingent, subject to complex bargaining, 
negotiations, issue-linkage, trade-offs, and 
sometimes coercion (Cortell & Davis, 1996; 
Finnemore & Sikkink, 1998). For both, the accounts 
of the ways in which international, local and 
national processes are intertwined, often raises 
questions about the legitimacy of global norms 
(Müller, 2013). Applied to global health policy, 
these analyses raise questions about how political 
or policy objects (such as AMR) move into different 
national and local levels. It also draws our attention 
to the ways in which the legitimacy of the topic 
under discussion is constructed and contested 
must be taken into account and raises questions 
about the absence of civil society actors, state 
actors from low-income African settings, in 
particular.   
 
Studies of policy by anthropologists are attentive to 
the relationships between politics and policy 
making and running throughout the 
anthropological accounts of different policy worlds 
and their impact is a concern with the ways in 
which policymakers and processes of policy making 
are involved in action that seeks to render technical 
political questions and concerns (Ferguson, 1994; 
Li, 2007). This process of rendering technical is not 
always successful and takes a good deal of on-going 
work but when it is a success then it can obscure a 
number of powerful forces shaping the problems 
under debate. Drawing on Foucault, development 
has been described as an ‘anti-politics machine’, 
making particular formulations of problems to be 
one of common sense rather than one formed in 
and from a particular historical moment (Li, 2007). 
How AMR policy works on more politicised 
elements of global public health, in particular 
claims to health-based human rights discourses 
around access to medicines will remain of 
particular concern.  
 
Anthropologists concerned with the relationship 
between global or international policy and practice 
have interrogated (ontological) questions about 
what policy is, how it is made and the effects that 
it may have. In his seminal and challenging account 
of international development policy, for example, 
Mosse argued that what makes good development 
policy is not its ability to provide a blueprint for 
effective action at grassroots level but rather its 
ability to legitimise practice and mobilise other 
actors to support it (Mosse, 2004). This means that 
the needs of the organisations that are 
implementing policy are likely to come first as the 
policy is made and discussed. According to Mosse, 
much of the work of enacting policy revolves 
around translating and representing their on-going 
work and its outcomes as part of this new policy 
domain. In this way, practice has been said to make 
policy rather than the other way around and the 
interpretative abilities of these policy/practice 
actors are shown to be critical. Yet, Mosse’s most 
controversial contribution to the literature is his 
argument that what is important in defining 
success within international development is not 
the inherent success of the project but the ways in 
which success itself is socially constructed. 
According to his account, we must always attend to 
the ways in which policy fails – which is likely to be 
not because it is ineffective or fails to enable 
change in the way that it prescribed but rather 
because the interpretive community around it falls 
apart or fails and with it an effective interpretation 
and narrative of success is also lost.  
 
One of the key ways in which policies on AMR are 
able to circulate and be a successful policy object is 
through its establishment as an issue for the globe 
rather than nation-states. The development of 
antibiotic resistance (ABR) is the key concern for 
most high-income settings and has been 
connected to concerns for the efficacy of 
medicines for malaria and HIV/AIDS under the 
broader category "AMR". This definition of the 
policy object as AMR rather than ABR is therefore 
central to its success as an object of global, rather 
than regional or national policy. Nonetheless, the 
temptation to only act on ABR remains powerful 
for actors from high-income settings. Whether the 
problem remains AMR or whether the term AMR is 
practiced as a set of activities against ABR remains 
to be seen. How these tensions between AMR and 
ABR impact on the policy problem and its ability to 
travel and provide an effective object around 
which action can take place will be of critical 
concern over the next years.  
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Anthropological accounts of policy are therefore 
likely to draw our attention to who makes the 
policy, how it reflects the immediate needs of the 
policy makers, how power relations effect what can 
be said and the construction of an interpretive 
framework through which others can be recruited. 
For AMR, the concern becomes then not "how well 
does AMR reflect real concerns in the world?" but 
rather what are the political and economic 
concerns that underpin and emerge through AMR 
policy, how are different projects and processes 
made to cohere as AMR, how is success 
constructed and how will these shape the ability of 
other political actors to become part of the 
interpretive community that will support the 
policy? What are the political processes (access to 
medicines, care, the role of markets and the state 
for example) that are likely to be rendered a 
technical matter that gets formulated in neutral 
language? What are the new forms of subjectivity 
that arise within this (people who waste, misuse or 
abuse antimicrobials), what new forms of morality 
and immorality are implied in these interventions? 
Tracing the debates that take place within global 
policy forums, understanding which elements of 
these discourses ‘echo’ effectively in different 
policy arenas and are taken up, the multiple 
concerns are made to cohere under the AMR, will 
be important research activities. Through analysing 
these, we will be better able to address who wins 
and who loses as AMR policies are drawn up and 
enacted and how it is that these winners and losers 
are positioned in this way (Gardner & Lewis, 2015).  
 
Anthropology of global public health 
Recent anthropological accounts of global public 
health as a field of practice have focused on 
indicators, on the ways in which care has been 
formulated and accessed in middle or low income 
settings in the last 15 years (Adams, 2016; Geissler, 
Rottenburg, & Zenker, 2012). Some have identified 
global public health as a collection of practices that 
placing a priority on improving health and 
achieving equity in health for all (Bozorgmehr, 
2010). Others, however, in attending to practices 
reveal a field that revolves around neoliberal 
formulations of public policy. For them, it is 
characterised by the targeting of public resources 
to particular diseases or recipients, governing 
health workers and patients from a distance, using 
projects and short- term programmes. These often 
rely on the circulation of commodities to achieve 
their aims and using indicators as a means to 
monitor and evaluate action are characteristic of 
global public health (Adams, 2016; Janes & 
Corbett, 2009). Just as the earlier literature 
described the symbolic power that medicines carry 
in many societies, in global public health 
pharmaceuticals appear at certain moments to 
have charm. They appear to be imbued with such 
power, so that they appear a magical solution to 
some of the most complex problems within and 
between societies. In relation to policy, the claims 
made of medicines is that their circulation will lead 
to an elimination of incurable diseases (Granich, 
Gilks, Dye, De Cock, & Williams, 2009) and perhaps 
most startlingly will be able to “make poverty 
history”, a claim that has been roundly challenged 
by Allen and Parker (Allen & Parker, 2012).   
 
Drawing on political economy, anthropologists 
concerned with how as the state has been rolled 
back and the institutions in which citizens can 
secure services have been hollowed out (Pfeiffer & 
Chapman, 2010), medicines have continued to 
circulate. This has led some to argue that in many 
settings public health has been reduced to the 
provision of pharmaceuticals, in other words, that 
is it has been pharmaceuticalised (Biehl, 2007). For 
Nguyen, the persistent asymmetrical access to 
resources between those seeking and those 
providing treatment for HIV, the availability of 
pharmaceuticals in the absence of other forms of 
public health have led to a re-forming of citizenship 
claims around medicines and a new form of 
therapeutic citizenship emerges (Nguyen, 2010).  
 
How these forms of action among policy makers 
and these forms of citizenship are challenged when 
medicines are rendered less efficacious or access is 
further restricted will be an important area for 
anthropological investigation and analysis.  
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Application of theory 
 
AMR reinforces and reanimates the role of 
pharmaceuticals in global health 
In the field of science and economics, there is 
evidence that AMR has become a spur for 
innovation (the creation of new medicines), the 
cracking open old, Darwinian ways of thinking 
about the world, startling researchers and creating 
moments of reflexivity. For global public health 
policy makers, researchers, programme 
implementers, AMR could be a profound challenge 
to pharmaceuticalised forms of care that rely on 
the circulation of medicines to act on health. It 
could be part of a process through which the limits 
of medicines to travel (and be used without 
significant consequences to their efficacy) is 
revealed and in so doing could new ways to act on 
health could be imagined and come into being. 
What is striking in the current policy discourse is 
that despite these challenges AMR does not work 
to decentre medicines and it has yet to open a 
space in which new practices or indeed more 
traditional public health practices emerge. Instead, 
policy documents continue to focus heavily on 
medicines, on finding ways to invest in order to 
increase the range of antimicrobial medications 
available and improve their use through the 
introduction of new health commodities - rapid 
point of care diagnostic tests - and through the 
improvement and upgrading of laboratories.  
 
It seems, therefore, that AMR is a new discourse of 
rather than a challenge to pharmaceuticalisation: it 
enables medicines to take up more ground in the 
policy discourse and re-animates their desirability 
as objects that deliver health around the world. If 
we take Foucault's argument that discourse is 
productive, then in turn, the questions must be 
asked of what becomes of this, what are the effects 
of simultaneously maintaining the central role of 
medicines to manage ill-health and disease and 
tackling AMR, what are the new forms of power 
that arise, how are they manifest?   
 
AMR narrows the goals and broadens the means 
of global public health  
In global public health, discussions of AMR and 
antibiotic resistance revolve almost exclusively 
around medicines and as they do, the discussion of 
medicines expands, vulnerable people seem to 
disappear and instead vulnerable medicines take 
their place. If we attend to the means and the ends 
of development, as Mosse (2004) suggests, we 
should then we see how under different agendas 
these means and ends of global health get 
reconfigured. Just as is the case in many 
development projects, the goals of action become 
increasingly limited and the means through which 
they are to be achieved expand. The aims of global 
health endeavours around AMR are rarely 
presented in terms of improving the health of 
people. Startlingly, improving health shifts to 
become a means - reducing cases of childhood 
diarrhoea, for example, is presented as a good 
opportunity for combating AMR, because fewer 
cases of childhood diarrhoea means that people 
are less likely to use antibiotics (O'Neill, 2016). 
 
 
Clare Chandler. Slum area Kampala, Uganda 
 
Discourses of AMR delink health and politics in 
novel ways 
As concerns of AMR are discussed, new processes 
are emerging that further delink health and politics 
as debates and access to medicines is rendered 
technical in novel ways. The space for political 
discussion around rights and access that has been 
central to the scaling up the use of antimicrobials 
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in low income settings, gets curtailed by concerns 
about AMR. In the World Health Organisation's 
Global Action Plan on AMR, for example, the most 
politicised debate in the field, - access to medicines 
- is acknowledged and then bracketed (World 
Health Organisation, 2015). But, there is more 
debate about the relationship between access to 
medicines and AMR than the WHO GAP suggests, 
and certainly those who can then lay claims to 
technical approaches to ensure better targeting 
seem likely to have taken them up. 
 
“Antimicrobial resistance is a drain on the global 
economy with economic losses due to reduced 
productivity caused by sickness (of both human 
beings and  animals) and higher costs of 
treatment. To counter it, long-term investment is 
required, such as financial and technical support 
for developing countries and development of 
new medicines, diagnostic tools, vaccines and 
other interventions, as well as health system 
strengthening to ensure more appropriate use of 
and access to antimicrobial agents.”  
(World Health Organisation, 2015) 
 
Discourses of AMR are laying the foundations for 
new forms of morality 
A good deal of emphasis on the management of 
AMR is through the provision of knowledge (about 
AMR) as a means through which people should 
reduce their use of antimicrobial medicines. These 
new discourses of AMR have the potential to lay 
out what it means to be a good, (productive) 
member of the body-politic and a member of its 
respectable citizenry - that is someone who does 
not 'abuse' medicines, who does not destroy a 
"public good" through their own use. As is common 
in economic theory, in these discourses many of 
these pit the needs and desires of the self-
interested, rational individual against society - and 
the idea that AMR is a form of tragedy of the 
commons has emerged as key trope in the 
narrative (Porco et al., 2012). These discourses 
about respectability do not only relate to 
individuals, the mapping of national actors in 
relation to AMR has also become a way of 
differentiating between national level 
governments. Rates of AMR have, for example, 
been correlated with levels of corruption, and 
those with high levels of resistance emerging as 
likely to be those with high levels of corruption 
(Collignon, Athukorala, Senanayake, & Khan, 2015). 
It seems likely that this will be extended to 
different state actors through potential legal 
agreements on reduction of antimicrobial 
resistance and there is an already emerging 
discourse differentiating between African 
governments who are "left behind", that is those 
that fail to act by refusing to take on particular 
policy objects.  
 
 
 
 
AMR/ABR Consolidates Euro American concerns 
and norms at the heart of global health 
AMR is a central policy object around which global 
health itself is being remade. It is facilitating new 
political alliances between industry, international 
organisations and governments, but access to 
these spaces or the debates has been restricted, 
and only those with a place around the table, with 
the finances and time to attend meetings are able 
to be part of these negotiations and discussions. 
 
The formal and informal discussions about 
antimicrobial resistance at global level have, been 
driven by a largely top-down process by European 
actors - UK, Scandinavian and German 
governments and the Europe, along with Australia 
and the United States and with little input from civil 
society (with the exception of Medicines sans 
Frontiers). The lack of involvement of African 
national governments, for example (with the 
exception of the governments of South African, 
Ghana and Kenya) and lack of statement by the 
African Union means suggests that their voices, so 
23
far, have not been heard in terms of formulating 
global AMR agendas.  
 
In terms of documentation, the O'Neill reports 
commissioned by the British Government were 
specifically devised with the aim of presenting AMR 
as a global problem to influence global debates, 
and be released in time for the 2016 World Health 
Assembly. While the accuracy of the figures 
presented in the reports has been questioned and 
senior members of O'Neill’s team continue to 
provide public reassurance that their startling 
statistics are accurate (Audi, 2016), these numbers 
and the formulations of the problems that they 
underscore have echoed in the most important 
global health meetings in Geneva (the 2016 World 
Health Assembly), and in New York (at the United 
Nations General Assembly (UNGA) high-level 
meeting held later in the year). The central role 
played by the UK government in placing AMR on 
the global agenda was also reflected in the claim of 
the UK's department for international 
development's press office, "UK secures historic 
declaration on antimicrobial resistance" following 
the meetings successful outcome.  (Department of 
Health (UK), 2016b).  
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Review of relevant theory 
Studies of science and its associated technologies, 
as well as their relation to practice, politics and 
society are a relatively recent area of research for 
anthropology. In spite of this, anthropological 
studies of the ways in which science and 
technologies are made and practiced is informative 
for reflecting on our understanding of AMR as a 
problem. Following in the footsteps of 
anthropologists who have shed new light on the 
construction of scientific facts such as human 
reproduction and women’s menopause (Lock & 
Kaufert, 2001), the formulation of AMR as a 
scientific object can be reviewed in the light of the 
linguistic and relational accounts within science, 
policy and society. Such work allows us to 
reconsider the ways we imagine AMR, and allow 
for the emergence of alternative ways to construct 
AMR as problem, offering other possible avenues 
for future intervention. 
 
A variety of fields have contributed to the 
development of current approaches to the study of 
science and technology within anthropology. A 
closer look at some of these contributions, in light 
of the current limited work by anthropologists on 
the science of AMR, will help highlight some 
potentially relevant empirical work and draw 
attention to theoretical, conceptual and 
methodological literature, which could benefit 
future AMR research and policy development. 
 
Science in practice 
The emergence of anthropologies of science in the 
1990s, was part of broader shifts – postcolonial, 
feminist, geopolitical, economic, political, cultural 
and intellectual -, which gathered momentum in 
the latter half of the twentieth century and 
challenged the exemption of the Western scientific 
establishment from political and cultural critique 
(Franklin, 1995). Previously, anthropologists had 
reserved the focus of their fieldwork for the study 
of cultures of non-European and North American 
societies. European and North Americans (except 
for First Nations and Native Americans) were 
largely exclude from anthropological work, since 
science was claimed as an exclusively Euro-
American practice. Contemporary anthropological 
approaches rather than accord science any special 
privilege, instead engages with it, as it does any 
other socio-cultural-material field. Latour and 
Woolgar’s (Latour & Woolgar, 1979) work on a 
biological laboratory in the US is exemplar of this. 
It is the first anthropological study to explore 
empirically the mundane practices, people and 
objects involved in the construction of scientific 
facts. This required them to extensively observe 
how scientists conducted their work in their 
laboratories, finances, paper writing, questions of 
scientific prestige, the roles of objects in their work 
and the complex relations between all of these in 
the production of scientific life and facts. It is this 
focus on the production and use of scientific 
research and facts, as well as technologies 
attributed to science – in laboratories, hospitals, 
government offices and everyday life –  that allows 
anthropology to go beyond official and published 
accounts of science (Bertoni, 2016).  
 
 
Louis Pasteur conducting an experiment (Britannica Online for 
Kids, 2016). 
 
The development of a focus on practice in 
anthropologies of science owes much to the recent 
work of Annemarie Mol and colleagues, such as 
John Law (2004), Andrew Pickering (1992), 
amongst many others. In her work on 
atherosclerosis in a Dutch hospital, Mol (2002) 
shows that atherosclerosis is more than a textbook 
description of the ‘gradual obstruction of the 
arteries.’ Rather, what atherosclerosis is, differs 
with the practices it is bound up in, each practice, 
whether it is observing, measuring, discussing, 
treating or operating, does a different version of 
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atherosclerosis. The implication is that the 
apparent singularity and coherence of 
atherosclerosis is an effect of a range of techniques 
and activities that coordinate different practices, 
such as conferences, medical images, forms and 
metrics, and doctor-patient consultations. This 
close focus on the practices of science and the 
objects involved in it, is essential to understand 
how science, technology, politics and society 
continually shape one another and the different 
forms they come in. A focus on how AMR is 
practiced across different spheres, will offer 
insights into what techniques are required to 
maintain it as an apparently, globally coherent 
object, and in doing so, also reveal what different 
practices are concealed. For example, what 
accounts of the importance of AMR are not being 
discussed by policy-makers, or what alternative 
forms of care to antimicrobials are already being 
practiced. 
 
 
 
 
Milk pasteurisation system  
 
Science, networks, histories, discourse 
History of science has further contributed to the 
methodological and conceptual development of 
anthropologies of science. Work, such as Shapin 
and Schaffer (1985) book on the 17th century 
Hobbes-Boyle debate on the air-pump experiment 
as a method to demonstrate the existence of a 
vacuum (space without air) or Haraway’s Primate 
visions (1989), have illustrated how a focus on the 
socio-cultural-material conditions that scientific 
research are embedded in, reveals the contingency 
of the knowledge produced, and how the society 
and science co-construct each other (Fischer, 
1999). A relevant development of this method and 
example for public health and microbes, is Latour’s 
book, The Pasteurisation of France (1993, 
published in French in 1984). In it, he demonstrates 
how the ‘victory’ of microbial theory of disease 
(over miasma theory) and the attribution of its 
success and development to Louis Pasteur cannot 
be reduced – purely - to his genius as a scientist. 
Rather, for Pasteur’s theory to triumph, he had to 
rely on the mobilisation of networks of a diversity 
of actors, including: public health hygienists, 
private and military medical professionals, farmers, 
industrialists, various technical equipment, the 
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French Academy, newspapers, journals, Louis 
Bonaparte and microbes, themselves. In other 
words, a focus only on the heroism of Pasteur, 
obscures the essential role that these other actors 
and activities (e.g. hygienist movements, 
colonialism and government deliberation) had in 
the success of his laboratory work in changing 
scientific understanding of disease and society in 
relation to hygiene practices, such as the 
pasteurisation of milk.  
 
A focus on networks, or actor-networks as labelled 
by Latour (ANT) (2005), allows us to describe the 
material-semiotics required to practice and 
produce science, with particular attention to the 
connections beyond the boundaries of scientific 
laboratories, illustrating the dependence of 
sciences on society and politics, rather than its 
independence. When combined with historical 
analysis, this allows us to reveal the contingency of 
networks and practices the role of shifting 
biological and social ideas in determining particular 
scientific understanding and technologies. 
Landecker’s (2015) work on antibiotics or Paxson’s 
on cheese and microbes (2012) provide relevant 
examples for anthropological approaches to the 
science of AMR. They can help us understand how 
the meanings associated with terms such as 
‘antibiotic resistance’ or ‘microbes’ can shift both 
historically, but also in different contexts, 
demonstrating the effects of scientific knowledge 
on the world, its potential limitations and the way 
alternatives can be side-lined or ignored as a 
consequence. For other historical work that have 
explored entanglements between science, politics, 
companies and publics, see for example the works 
of: Robert Budd (2007); Scott H Podolosky (2014); 
and Quinn (2013). These works also touch on 
public, political, corporate and scientific discourse, 
which offers fruitful insights into popular 
perceptions about science, the political and partial 
mobilisation of scientific evidence and language 
(such as metaphors) that influence scientific 
concepts. For contemporary applications of 
discourse analysis relevant to antimicrobial 
resistance, see: Brown and Crawford (2009) and 
Nerlich, Brigitte and James, Richard  (2009) on war 
metaphors and catastrophic discourse; Brown et al 
(2009) on biosecurity, hygiene and superbugs; 
Brown and Nettleton (Forthcoming-a) on blogs, 
immunity and xenophobia. 
 
Anthropology beyond humans  
Anthropology’s focus on science, is now 
accompanied by increasing interest and 
exploration with other nonhuman organisms and 
our relations with them. This shift in focus has 
been referred to as the ‘species turn,’ indicating a 
growing number of anthropologists’ attempts to 
go beyond humans and take the lives of other 
species seriously. In this sense, it has become a 
sub anthropological genre in its own right, and is 
broadly grouped under the term ‘multi-species 
ethnography’ (see for example S. E. Kirksey & 
Helmreich, 2010 and others in the same Cultural 
Anthropology special issue for some discussion of 
its emergence and examples of relevant texts). 
 
Multi-species ethnography builds on the insights 
on the multiplicity of objects in practices and 
other critiques of the nature/culture dichotomy. 
In doing so, it seeks to contribute to better 
understanding how we live with and against other 
species (e.g. mammals, insects, fungi and 
microbes), their conceptual and material relations 
with humans and the ways that economic, 
political and cultural processes shape them. 
Donna Haraway’s work with and on dogs as 
‘companion species’ offers a key starting point for 
understanding how the power of a multi-species 
approach troubles questions of human 
exceptionalism, agency and the nature/culture 
dichotomy (Haraway, 2008). Her focus on the co-
existence of humans and dogs through processes 
of domestication, co-evolution and training 
amongst many others, shows how these 
processes have (and continue to) shape and 
transform not only dogs, but also their owners, as 
well as the way they co-produce niches and 
ecologies (Haraway, 2008; Kirksey & Helmreich, 
2010). Anna Tsing’s recent work on Matsutake 
mushrooms (Tsing, 2015), in addition to Donna 
Haraway’s (2008), demonstrates what Kirksey 
(2014 p3) identifies as an important aspect of 
much multispecies work, which is a focus on what 
it means for humans to live with and against other 
species, rather than grappling with the difficult 
question of how to speak for other species. In 
addition, such a focus also benefits from 
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examining, ‘Who benefits, when species meet?’ 
(Kirksey & Helmreich, 2010). Multispecies work 
has also extended to human microbial relations, 
which may be of special interest to work on 
antimicrobial resistance: see for example Heather 
Paxson’s (2012) work on cheese production and 
pasteurisation or Cecila Lowe’s (2010) work on 
the influenza virus in Indonesia. 
 
Drawing on the multispecies literature and some 
of the concepts it offers, will provide fruitful 
avenues for studying the many ways that 
antimicrobial resistance comes into being, is 
spread and the multiple species that may be 
involved in these processes. Here, anthropologists 
employ concepts in common with scholars of 
science and technology, “the earthy and muddled 
and tenacious engagements afforded by 
‘ecologies’, ‘infrastructures’ and ‘entanglements’ 
have brought new sources of analytical vitality and 
valence to anthropological theory. These are 
languages of description that conjure worlds of 
material and biotic interdependencies, human and 
non-human agencies weaving themselves into and 
around filaments of energy, matter, history and 
decay” (Jiménez, 2017).  
Multi-species ethnography offers anthropology of 
science and interdisciplinary research more 
broadly, a way to empirically explore the 
contingency of human-nonhuman-antibiotic-
microbe relations in the production and 
movement of AMR, the specificity of contexts 
where it arises and the different responses 
mobilised. In addition, multispecies ethnography 
may also provide a fruitful source of inspiration 
for diverse ways of, not only living with and 
against microbes (as well as other animals), but 
also the ways we talk about relating to them in 
the first place (i.e. beyond discourses of war 
against bacteria and apocalypse).  
 
 
 
Cheese made from human bacteria. Image from: Wainwright, O. (2013). "Grow Your Own: where scientists and artists are shaking 
up creation." Retrieved 1 August, 2016, from https://www.theguardian.com/artanddesign/2013/oct/28/grow-your-own-synthetic-
biology. 
 
 
  
30
Application of theory 
 
Antibiotics transformed human and bacteria, 
and back again 
The discovery of antibiotics has transformed 
human societies through their incorporation into 
daily health care practices, from treating previously 
fatal infections to increasing the possibilities of safe 
surgical operations, as well as also increasing 
agricultural food productivity (see for example, 
Amyes, 2001). However, their mass adoption and 
use has in turn led to significant transformations. 
The work of the sociologist and anthropologist, 
Hannah Landecker’s (2015) proves insightful, 
particularly her paper, Antibiotic resistance and the 
biology of history. She draws attention to how the 
promotion and use of antibiotics for human and 
animal health (and growth) is now evident as 
biological fact, not only in bacteria that they were 
designed to target (i.e. through creating selection 
pressures for resistance strains), but also the 
biology and ecology of soils, water, and animals, as 
well as our own guts (Landecker, 2015). This is 
both, in the form of an increasing prevalence of 
antibiotic resistant genes in microbes in different 
settings (Knapp, Dolfing, Ehlert, & Graham, 2009; 
Zhu et al., 2013), but also shifts in the presence, 
abundance and diversity of different microbes due 
to antibiotic use (Cleary et al., 2016; Gutiérrez, 
Watanabe, Harter, Glaser, & Radke, 2010; 
Matsuura & Garrison, 2011; Paterson, 2004). In 
other words, antibiotics have transformed human-
bacteria relations and associated infections, which 
has also changed the biology of bacteria (resistance 
or death), potentially rendering the sustainability 
of current antibiotic-related practices, ineffective. 
In short, antibiotics transformed humans and 
bacteria, which has consequently, required 
humans to transform their relations to antibiotics; 
and also, potentially, to bacteria. 
 
Human ideas transformed humans and bacteria, 
and back again 
It is not only the biology of bacteria that has 
changed since the adoption of antibiotics, but also 
the very ideas about antibiotics and bacteria  
(Landecker, 2015). A clear example of these 
changes is in the scientific knowledge of the 
development bacterial resistance to antibiotics.  
 
The work of multiple scientists in the nineteenth 
century (such as Pasteur and Koch) meant that 
beginning in the mid-nineteenth century it was 
possible to blame bacteria as infectious pathogens, 
for many of human ills,  and later envisage 
antibiotics as ‘wonder’ drugs that could come to 
our rescue (R. Bud, 2007a). A number of scientists, 
including Fleming, raised questions of bacterial 
evolution of resistance to antibiotics as a potential 
obstacle to their mass adoption. However, these 
warnings went largely unheeded (Nathan & Cars, 
2014). At the time, bacterial resistance was 
believed to evolve due to antibiotics acting as 
selection pressures for resistant genes in bacterial 
populations, which were then only inherited 
vertically during bacterial replication (Landecker, 
2015). However, a number of developments in 
genetics, evolutionary biology and microbiology 
means that these ideas are now partial, if not 
largely obsolete. Firstly, the discovery and 
characterisation of the horizontal transfer of 
genetic material between bacteria, shifted 
understandings of bacterial mechanisms for the 
dissemination of resistant genes, including across 
species lines, and their evolutionary change. This 
challenged previous ideas of antibiotic induced 
bacterial evolution, where some assumed that 
vertical inheritance – and judicious use of 
antibiotics – was sufficient to avoid AMR becoming 
a matter of public health concern. Bacteria’s ability 
to transfer genes carrying resistance to antibiotics 
both horizontally and vertically outstripped 
previous scientific ideas of bacteria-antibiotic 
relations. 
 
The second development is the discovery and 
increasing understanding of the human 
microbiome, which has accelerated dramatically in 
the last two decades (Dave, Higgins, Middha, & 
Rioux, 2012; Grice & Segre, 2012). This has led to a 
growing number of scientists drawing attention to 
significant shifts in our gut microbiota, as a 
consequence of continued exposure to antibiotics 
(Abeles et al., 2016; Liu, Wu, Ying, Luo, & Feng, 
2012; Matsuura & Garrison, 2011; Paterson, 2004; 
Yassour et al., 2016); typically in the form of direct 
intake of antibiotic medication, but with increasing 
attention to the ingestion of antibiotics residues in 
food or water (Darwish et al., 2013; Sanz et al., 
2015; Sapkota et al., 2008). Microbiology, and 
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genetic epidemiology research is beginning to 
elucidate associations between exposure to 
antibiotics and negative consequences for our 
health, with potential links to increases in obesity, 
diabetes, asthma and irritable bowel syndrome, 
amongst others (Bennet, Ohman, & Simrén, 2015; 
Cox & Blaser, 2015; Mikkelsen et al., 2016).  
 
The deficiencies of previous scientific knowledge 
and perhaps, some would say, myopia, are a 
central determining factor for the scale of present 
reports of global AMR prevalences and emerging 
fears of a post-antibiotic apocalypse, as well 
potentially contributing to observed increases in 
some negative health outcomes. Thus, human 
ideas changed the biology of bacteria and our 
microbiota, now it is humans’ ideas that are having 
to change in response to AMR.  
 
A failed antibiotic future 
Scientific knowledge was insufficient in-itself to 
mitigate the current AMR predicament. Fleming 
and others’ early warnings of the risks of bacterial 
resistance to antibiotics fell on deaf ears (Podolsky 
et al., 2015). They lacked the strong social networks 
that other scientists, governments and large 
corporations could mobilise to sell antibiotics, 
inform policies and regulation, and influence 
publics. Fleming and other scientists’ politics of 
antibiotics use (i.e. care to mitigate against the 
development of resistance) had little immediate 
impact. Instead, other scientists were involved, 
together with health professionals and 
pharmaceuticals in actively developing and 
promoting antibiotics as ‘miracle drugs’ (Bud, 
2005, 2013; Podolsky, 2014) and a future where 
bacterial pathogens would be completely 
controlled (Paxson, 2008), if not eradicated.  
 
The reasons that the realisation of this twentieth 
century vision of future failed, in retrospect 
appears obvious. Firstly, the limitations of scientific 
knowledge at the time meant important 
bacteriological properties were overlooked (e.g. 
horizontal transfer of resistance genes was not on 
the radar nor was the human microbiome). 
 
Newsweek cover, October 17, 2013. 
 
Second, myopic speculations based on existing 
knowledge at the time, failed to account for the 
partiality of scientific facts (their fallibility and 
historical contingency) and the inability to mobilise 
complex social, political, cultural and economic 
factors to attempt to successfully enact such a 
future. Lastly, antibiotics and scientific knowledge 
of bacteria, were not mobilised for purely health 
ends, but for multiple, but not always mutually 
exclusive ends, such as financial profits, military 
campaigns and political agendas etc. This last point 
is all the more pertinent now, as antibiotics have 
emerged again in public and political arenas. 
Rather than an explicitly emphasising health-ends, 
these cries focus on saving antibiotics (Alliance to 
Save Our Antibiotics, 2016). A focus on these cries, 
raises questions as to what rationalities motivate 
them and what new antibiotics futures are they 
attempting to conjure.  
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The post-antibiotic apocalypse: A selective 
image of science 
 
 
Image from: Gallagher, J. (2015). "Analysis: Antibiotic 
apocalypse." Retrieved 20 October, 2016, from 
http://www.bbc.com/news/health-21702647. 
 
The relatively recent re-emergence of antibiotics in 
public and policy spheres, as AMR, has occurred 
amidst wide deployment of war metaphors and 
catastrophic discourse. Fear and warnings of 
antibiotic resistance have existed since the 
discovery of penicillin. However, these metaphors 
and tropes  have increasingly become common 
mantras in popular science, policy and media 
circles, warranting analysis (e.g. B. Brown et al., 
2009). Some scientists, policy-makers and 
politicians have even begun prophesying a return 
to a ‘pre-antibiotic dark ages’ or ‘post-antibiotic 
apocalyptic’ future, if immediate action is not taken 
(Chan, 2012; Department of Health (UK), 2016a; 
Harbarth et al., 2015; Walsh, 2014). At face value, 
these catastrophic prophecies may appear 
innocuous, even necessary to draw attention to the 
perceived urgency of AMR, garner funding, political 
support and catalyse action to save antibiotics 
from bacterial resistance (B. Brown et al., 2009). 
However, the reduction of bacterial resistance 
biology to war metaphors and catastrophic 
discourse and the frequent, absence of discussion 
of social, political and economic factors from many 
accounts, in order to grab attention and motivate 
action, depends on partial and selective use of 
scientific facts. 
 
While the science of antibiotic resistance 
undoubtedly provides the impetus for action (i.e. in 
the form of so-called evidence-based medicine), its 
reduction to war and catastrophic discourse is 
deemed necessary to convey the so-called 
‘essence’ of complex problems to lay people (for a 
reflection on scientific reduction and simplication 
of science, see Yates-Doerr, 2012, work in relation 
to nutritional education), especially when they 
need to compete with other subjects in public and 
political spheres. However, what scientific 
knowledge is left out, can have significant 
consequences, such that the selective use of the 
‘facts’ of AMR, facilitate its ability to become 
subservient to political and ideological agendas, so 
as to forward particular political, economic and 
social ends. For example, Brown and Nettleton 
(Forthcoming-a) shows how AMR is employed as 
political arena for passing blame in Labour-
Conservative party politics or used as a xenophobic 
device to denigrate immigrants and attempt to 
justify why they should be kept out of the UK. 
Similar, blame-games are popularly levelled in 
media and political discourses, framing doctors as 
over prescribers and patients as, misusers and 
over-consumers of antibiotics, with selective 
and/or limited attention, intentional or not, to 
contributions of socioeconomic inequalities and 
inequities, demographics and differences in 
exposures to infectious diseases, let alone the 
pharmaceutical industries role in the levels of 
antimicrobials sold (see Ravelli, 2011, for an 
analysis of pharmaceutical marketing of antibiotics 
to doctors in France). Here, blame is passed down 
hierarchies of political and economic power, side-
stepping governments, scientists and 
pharmaceutical companies, to those prescribing 
and consuming them (whether human or 
livestock), with low and middle income countries, 
in general, consistently reported as lacking 
requisite knowledge and resources; hence, 
described as acting irrationally and ‘still’ 
overconsuming antibiotics (Lambert, 2016). 
 
This selective engagement with antibiotic science 
and bacteriology is also evident in the proposed 
solutions to AMR, two of the most commonly cited 
are (AMR Policy Team, 2016): to reduce antibiotics 
use and increase investment and incentives for 
further drug development. These solutions appear 
as seeds of particular visions of a future, where 
science, medicines, society and economics are 
deeply entangled – a fact, which is perhaps, not 
untrue of the antibiotics past and present. There 
communication amidst war metaphors and 
catastrophic discourse, as well as national and 
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global security fears, perpetuates a partial view of 
microbes as a unilateral source of danger to human 
society. Here, war is popularly presented as one, if 
not the only technique and discourse of ‘choice’ to 
engage with microbes, if we are to avoid a post-
antibiotics apocalypse and prevent the end of the 
modern medically-enhanced world as we know it 
(Chan, 2012; Department of Health (UK), 2016a). 
However, the science of antibiotics and bacteria 
casts doubt on the ability of reducing antibiotics to 
mitigate AMR and raises questions about whether 
producing new medicines is not just another way 
of perpetuating this problem in the name of future 
financial gains for pharmaceuticals (N. Brown & 
Nettleton, Forthcoming-b). At present, what often 
seems to be missing from high-level political 
discussion and public debates of antibiotic science 
are serious engagement with: the implications of 
horizontal gene transfer for persistence and spread 
of AMR; consideration of the negative 
consequences of antibiotics on our microbiomes 
and health; and the serious inequalities and 
inequities tied up with antibiotics resistance, 
access to antibiotics and health care, more broadly. 
Perhaps this is a drawback of the assumed 
separation of politics and society from science – 
the former is inadequately prepared, and perhaps 
unwilling to fully engage with some emerging 
developments in the latter. Whatever the reasons, 
more serious space should be given to the above 
factors, so that any attempt to imagine a medical 
future does not reduce it only to saving medicines 
and greater investments in them, but also seeks to 
take seriously questions of microbial ecology (e.g. 
collateral damage to microbiomes) and 
socioeconomic inequalities and inequities. 
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Conclusion 
 
 
 
Does AMR represent the end  
of modern medicine? 
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In this report we have set out a framework of three 
arenas in which it can be productive to apply social 
theory to AMR: antimicrobials in practice, AMR 
policy and AMR science. Through our reviews we 
have introduced a range of theory applicable to 
each arena, in particular from anthropology, and 
we have then provided worked examples as 
illustrations for applying this theory to stretching 
our conceptualisations of AMR as a problem and 
potential ways to address it. 
 
A central tenet to all these approaches is the 
making visible of what we take for granted as 
established. Theories help us to take on new 
perspectives when attending to what is said, 
whether in the media, policy, science, literature or 
in public, what is observed in practice, and the 
imaginings, expectations, relationships and 
materialities that link the two.  
 
Antibiotics are one of the most commonly used 
groups of medicines globally, and are undoubtedly 
a lynch pin of many contemporary medical and 
healthcare practices. They have not only been able 
to treat and cure many previously deadly 
infections, but they have also enabled surgical 
procedures, which would have previously not been 
carried out for fear of infection. The recent 
emergence of AMR on national, and increasingly on 
global agendas, in a large part, spawns from fears 
of losing the health gains that antibiotics have 
contributed over the last sixty plus years. These 
fears have been expressed as doomsday cries of 
returning to the ‘dark ages of medicine’ (Walsh, 
2014), a pre-antibiotic past, or in the form of 
apocalyptic prophecies of entering a ‘post-
antibiotic era’ (BBC News, 2015). These 
statements, on a number of occasions, have been 
accompanied by predictions that a post-antibiotic 
era, which AMR is deemed to spell, will mean ‘...an 
end to modern medicine as we know it’ (Chan, 
2012; Department of Health (UK), 2015), leading 
some to call for antibiotics and by proxy, modern 
medicine to be ‘saved’(Holpuch, 2016).  
While the effects of AMR on treatment outcomes 
is unquestionable, such broad scale predictions 
about the end of modern medicine suggest more is 
at stake, both for people and for biomedicine itself 
and the systems with which it is interdependent.  
 
The approaches outlined in this report prompt us 
to ask, ‘what matters’ and to whom. Attending to 
this question, and drawing on some of the 
theoretical perspectives outlined in this report can 
provide insights into what ‘modern medicine’ 
means to different involved parties (e.g. those in 
need of antibiotics, policy-makers, health care 
professionals and pharmaceutical companies) and 
therefore what is perceived to being lost and why 
it is of concern. It also then allows us to ask what is 
believed should replace it – whether it is more 
medicines and/or other forms of care.  
 
By applying techniques of counterfactuals (such as 
inversions in Part 1, analysis of means/ends in part 
2 and science in practice in Part 3), this report has 
shown how we can map out different ideas of what 
the future of medicine could be and for whom, 
what different scientific knowledges may be 
relevant and how they could affect politics and 
society. What would, for example, a post-modern 
medicine look like, and how can and will our 
framings shape it?  
 
In summary, this report has presented a series of 
applications of social theory to understanding and 
addressing antimicrobial resistance, in the practice 
of medicines, in AMR policy and AMR science. This 
has allowed us to see the multiplicity of the topic 
of AMR, and how we can come to see what is often 
obscured from view in our current framings, and to 
see how different versions of AMR and the 
problems it poses can come to the fore through the 
application of different theoretical perspectives.  
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